Senescence in pancreatic carcinogenesis: from signalling to chromatin remodelling and epigenetics.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23408353.
- Also identified by DOI 10.1136/gutjnl-2012-302793.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mutational activation of K-Ras is a key genetic event involved in the initiation of pancreatic carcinogenesis. However, K-Ras generally fails to transform precursor lesions into invasive cancers due to activation of powerful fail-safe programmes that counteract transformation and growth. The importance of cellular senescence, a permanent cell growth arrest, is increasingly being recognised as a critical fail-safe programme in pancreatic carcinogenesis. Emerging evidence suggests that oncogene-induced senescence requires transcriptional induction of the CDKN2A gene locus as well as comprehensive chromatin modifications involved in epigenetic silencing of pro-proliferative genes. Moreover, recent work in pancreatic cancer mouse models proposes that inactivation of the CDKN2A tumour suppressor locus is the molecular switch required for senescence evasion and unleashed K-Ras driven malignant transformation in the pancreas.
Medical subject headings
- Carcinogenesis
- Cellular Senescence
- Gene Silencing
- Genes, p16
- Genes, ras
- Pancreatic Neoplasms